Method for expressing polypeptide having anti-tumor activity

Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12P 2102

Patent

active

051513498

ABSTRACT:
Disclosed is a human TNF derivative with a reduced tendency to cause adverse side effects that is obtained by replacing the 31st and 32nd arginine residues from the N-terminal of the amino acid sequence of human TNF, which has a potential for causing serious adverse effects, with asparagine residue and threoine residue, respectively, as well as a method of preparing the same utilizing recombinant DNA technology.

REFERENCES:
Nakamura et al., EMBO 1:771-775 (1982).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method for expressing polypeptide having anti-tumor activity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for expressing polypeptide having anti-tumor activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for expressing polypeptide having anti-tumor activity will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1967900

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.